Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle┬«) technology, today announced…

Automakers are offering extreme deals. Car buyers should proceed with caution

A number of car companies, including Fiat Chrysler (FCAU), General Motors (GM) and Hyundai (HYMTF), are offering 84-month car loans at 0% interest. That’s seven years without any interest. Others…